Drug developed to suppress cancerous tumors also has ability to lower blood sugar levels that were elevated due to obesity and Type 2 diabetes.

Researcher at Harold Hamm Diabetes Center receives $1.6 million NIH grant to better understand how non-alcoholic fatty liver disease (NASH).

OU Health to receive more than $1 million to participate in a National Institutes of Health (NIH) initiative to better understand long-term effects of COVID-19 infection.

Min Li, Ph.D., George Lynn Cross Research Professor of Medicine, has been designated president-elect of the American Pancreatic Association.